Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP
This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers
This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
Becomes the first rehab & recovery center in east India to earn NABH accreditation
The partnership marks a significant milestone in integrating digital health education into medical curricula
The fresh funds will be used to enhance customer relationships, expand operations and develop state-of-the-art service
Revenue from operations stood at Rs. 313.4 crore during Q1 FY25
The inspection was concluded with zero observations
Research & Development (R&D) investments for the quarter stood at Rs. 392.5 crore which is 6.3% of its revenues
Our centers are performing as expected or even better
Subscribe To Our Newsletter & Stay Updated